Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To evaluate the benefits and harms of immediate‐release methylphenidate compared with placebo or other pharmacological interventions for treating attention deficit hyperactivity disorder (ADHD) in adults.